Evercore ISI's Umer Raffat weighed in on Valeant Pharma (NYSE: VRX) following press reports last night on Philidor's drug dispensing ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Valeant Pharmaceuticals (VRX) Bull-Bear Debate RagesOctober 30, 2015 12:57 PM Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-TermOctober 30, 2015 10:14 AM Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference CallOctober 30, 2015 8:53 AM Valeant Pharma (VRX) to Sever Ties with PhilidorOctober 30, 2015 5:59 AM Valeant says Philidor pharmacy shutting down as it cuts tiesOctober 30, 2015 5:42 AM Valeant To Terminate Relationship With PhilidorOctober 30, 2015 5:00 AM Valeant Pharma (VRX) Plunges as Philidor Practices Questioned, PBMs Cut TiesOctober 29, 2015 5:19 PM UPDATE: Philidor said to Modify Prescriptions to Boost Valeant (VRX) SalesOctober 29, 2015 4:49 PM